Journals / Ege Tıp Dergisi / 2000 / Cilt: 39 - Sayı: 1

Stage I invasive cervix carcinoma: SSK Ege Maternity Hospital experience

Evre I invaziv serviks karsinomları: SSK Ege Doğumevi ve Kadın Hastalıkları Eğitim Hastanesi deneyimi

Pages
51–55
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is recognised that recurrence and lymph node involvement rates increase when the depth invasion increases. 5-year survival rate was found as 88.56 % in our series.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To assess the risk factors that increase the recurrence rate in the cases treated for stage I cervical cancer.
📊
Key Findings & Data:Department of Gynecologic Oncology, SSK Ege Maternity Teaching Hospital. 117 FIGO stage I cervix carcinoma cases were treated between 1986 and 1996 in our clinic. 64.9% (76/117) of the patients primarily underwent radical hysterectomy and pelvic-paraaortic lymphadenectomy, while radiotherapy was performed to 66% (77/117) cases as primary or adjuvant treatment modality.
💡
Conclusion & Impact:It is recognised that recurrence and lymph node involvement rates increase when the depth invasion increases. 5-year survival rate was found as 88.56 % in our series.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Adenokarsinom · Serviks neoplazmları · Radyoterapi

Abstract

To assess the risk factors that increase the recurrence rate in the cases treated for stage I cervical cancer. Department of Gynecologic Oncology, SSK Ege Maternity Teaching Hospital. 117 FIGO stage I cervix carcinoma cases were treated between 1986 and 1996 in our clinic. 64.9% (76/117) of the patients primarily underwent radical hysterectomy and pelvic-paraaortic lymphadenectomy, while radiotherapy was performed to 66% (77/117) cases as primary or adjuvant treatment modality. Treatment modalities, histologic type, lymph node involvement, invasion findings, and recurrences were documented. Epidermoid carcinoma was found in 103 patients (88.4 %), adenocarcinoma in 13 (10.7 %) and sarcoma in one (0.9%). Fourteen cases were stage Ia1, eight were stage Ia2 and 94 were stage Ib. Lymph node involvement was observed in 41% of the cases having parametrial involvement. Genitourinary fistula was the most encountered morbidity with the rate of 3.9 %. It is recognised that recurrence and lymph node involvement rates increase when the depth invasion increases. 5-year survival rate was found as 88.56 % in our series.

Özet

Evre I serviks kanseri nedeniyle tedavi edilen olgularda rekürrens riskini arttıran faktörlerin incelenmesi ve yaşam şansının belirlenmesi. S.S.K. Ege Doğumevi ve Kadın Hastalıkları Eğitim Hastanesi Onkoloji Departmanı. 1986-1996 yılları arasında serviks karsinomu tanısı alan 443 olgudan FIGO sınıflamasına göre evre I grubunda 117 olgu (% 26.4) tedavi edildi. Risk faktörü taşıyan 77 (% 66) olguya radyoterapi uygulandı. Uygulanan tedavi modaliteleri, histolojik tip, lenf nodu tutulumu, invazyon bulguları ve rekürrensler dökümante edildi. 103 olguda (%88.4) epidermoid karsinom, 13 olguda (%10.7) adenokarsinom ve 1 olguda (%0.9) sarkom saptandı. 14 olgu evre Ia1, 9 olgu evre Ia2 ve 94 olgu evre Ib olarak değerlendirildi. İnvazyon derinliği arttıkça rekürrens ve lenf nodu tutulumunun arttığı gözlendi. Seride 5 yıllık yaşam şansı %88.56 olarak hesaplandı.

🔖

Cite This Article

HANHAN, M., VARDAR, E., KELEŞ, R., ÖZBAKKALOĞLU, A., İNAL, M. (2000). Stage I invasive cervix carcinoma: SSK Ege Maternity Hospital experience. Ege Tıp Dergisi, Cilt: 39 - Sayı: 1, 51–55. https://ajindex.com/articles/223118

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Armstrong BK, Munoz N, Bosch FX: Epidemiology of cancer of the cervix. İn Coppleson M (ed), Gynecologic Oncology, 2nd Edition, Volume 1 Churchill bringstone, Edinburg London 1992;11
  2. Aydınlı K, Bozkurt S, Erkin E, Atasü T: Kadın Genital Kanserleri Insidansı. Jinekoloji ve Obstetrik Dergisi1987; 1:33
  3. Ayhan A, Tuncer ZS, Koseoglu F, Yüce K, Kucukali T: Microinvasive carcinoma of the cervix: an analysis of 31 patients. Eur J Gynaecol Oncol 1997;18(2):127-129 4. Güner H, Serviks Kanseri, Jinekolojik Onkoloji 1994
  4. Ceardin E, Schmidt RW, Robrets JA. Prognostic factors and relapse patterns in early stage cervical carcinoma after brachitheraphy and radikal hysterectomy. Gynecol. Oncol 1994;53 (3):317-319
  5. Disaia PJ, Creasman WT, Clinical Gynecologic Oncology. The C. V. Mosby Co. 1984;chapter 3
  6. Burke TW, Haskins WJ, Heller PB, Bibram C, Wanser EB. Clinical patterns of tumor recurrence after hysterectomy in stage IB cervical carcinoma. Obstet. Gynecol. 1987;69: 382
  7. Wright TC, Kurman RJ, Ferenczy A: Precancerous Lesions of the cervix. İn Kurman RJ (ed): Blaustein's pathology of the female genital tract
  8. Ed. Springer Verlag, New York, 229, 19 9. Piver MS, Rose Freedman MF: Changes in FIGO staging. Am. J Obstet Gynecol 1988:158:678
  9. Burghardt E, Girardi F: Local spread. İn Burghardt E (ed), Surgical Gynecologic Oncology, Georg Thieme Verlag 1993;203-212
  10. Schmidt MH, Kühnle H: Paeneoplasien und Neoplasien der Cervix Uteri. Klinik der Frauenheilkunde und Geburtshilfe, Band 11, Urban und SchWarzenberg, München, 1991;3:129
  11. Gilly G, Gilly L: Lungen und Knochenmetastasen bei malignen Uterustumoren Geburtshu Frauenheilk 1969;29:505
  12. Lee Y, Wang KL, Lin MH, Liu CH: Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer; A clinical revieW of 954 cases. Gynecol Oncology 1989; 32:135-142.